Statement To the FDA Risk Management Advisory Committee

February 26, 2009
FDA 2-26 Statement of Consumers Union
37.3 KB

Consumer Union urges faster action on the development of simple, non-duplicative, objective, useful prescription drug safety information for consumers.

IssuesHealth
Experts
You Might Also Be Interested In
press release
November 23, 2020
Consumer Reports Renews Call For Mandatory COVID-19 Safety Standards For Airlines and Airports As Holiday Travel Season Begins
November 13, 2020
Consumer Reports letter to Senate Commerce Committee opposing S 4613, Contact Lens Rule Modernization Act
October 16, 2020
Joint amicus brief in defense of California law prohibiting anti-competitive generic drug pay-for-delay deals
September 8, 2020
CR comments to Copyright Office supporting renewal of pro-consumer exemptions from section 1201 of Digital Millennium Copyright Act